Dihexa (N-hexanoyl-tyrosine-isoleucine) is a synthetic peptide derived from angiotensin IV that is being studied within neurobiology for its potential influence on brain-related processes. In laboratory and preclinical settings, it has been investigated for its interaction with signaling pathways associated with synaptic activity, learning, and memory, as well as its ability to cross the blood-brain barrier.
It is important to note that Dihexa is strictly a research peptide (RUO) and is not approved for human use. Any references to potential effects are based on early-stage research and do not constitute medical claims or proven therapeutic applications, including for conditions such as Alzheimer’s disease.
